United States
Germany
Japan
United Kingdom
China
Anti-NKG2A antibody(DMC298), IgG1 Chimeric mAb
| Applications | FC |
| Reactivities | Human |
Products
Anti-NKG2A(monalizumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
Anti-NKG2A antibody(DMC298), IgG1 Chimeric mAb
| Applications | FC |
| Reactivities | Human |
Anti-NKG2A(monalizumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
